Recent data indicates that up to 5% of the population suffers from bipolar spectrum disorders; as a result, this disabling group of disorders represents a significant proportion of the clinical workload of mental health practitioners.
Although Lithium and Chlorpromazine have been used in mania for at least 50 years, it is only in the last decade that a great diversity of anti-manic and mood stabilizing agents have become available in clinical practice. Bipolar Psychopharmacotherapycovers both pharmacotherapy and the role of psychotherapy, psychoeducation and social approaches to provide a broad integrative philosophy of care for bipolar patients. Extensive coverage is given to special management issues such as the care of women with bipolar disorder, children and the elderly, as well as bipolar depression and suicide prevention.
With contributions from the pioneers in the field and an expert editor team, Bipolar Psychopharmacotherapy provides psychiatrists and all mental health practitioners with an invaluable guide to the management of these complex patients.
Hagop S. Akiskal